The Mark Foundation for Cancer Research and the Chordoma Foundation invite proposals that will accelerate the development of new strategies to target the chordoma surfaceome. We seek projects aimed at enabling or enhancing the feasibility of targeting TBXT pMHC or other tumor-specific surface targets. Competitive proposals will generate broadly enabling datasets, tools, technologies, or mechanistic insights that facilitate the development of multiple therapeutic modalities. Areas of interest include basic and translational research, and preclinical proof-of-concept studies that de-risk future therapeutic development.

Please review the RFP webpage before applying.